Crowdsourcing to better forecast drug approvals
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
Fellowship applications open on May 3, 2021 for entrepreneurs working and living in Ethiopia, Ghana, Nigeria, Kenya, Rwanda, Senegal, and Uganda.
By
Integrating robots into a manufacturing system is often prohibitively expensive. A new approach could change that.
By
Maria Ressa built a successful media startup — and exposed human rights issues — while fighting disinformation and attacks from the Philippine government.
By
Machine learning is a powerful form of artificial intelligence that is affecting every industry. Here’s what you need to know about its potential and limitations and how it’s being used.
By
Companies make common data science mistakes. Here’s an expert’s guide to what they are and how to avoid them.
By
What are the sources of resilience and renewal in America’s small towns and rural areas?
By
“Building Sustainable Healthcare Systems through Innovation and Entrepreneurship” will bring together entrepreneurs, academics, healthcare professionals and policymakers from around the world.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
USA Lab is available to MIT Sloan students and graduate students from across the broader MIT campus.